Search Ontology:
ChEBI
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
- Term ID
- CHEBI:65132
- Synonyms
-
- (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-CoA
- (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl-coenzyme A
- (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-coenzyme A
- 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]sulfanyl}ethyl)amino]-3-hydroxy-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
- 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl-CoA
- 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl-coenzyme A
- cervonyl CoA
- cervonyl coenzyme A
- cervonyl-CoA
- cervonyl-coenzyme A
- CoA(22:6(4Z,7Z,10Z,13Z,16Z,19Z))
- DHA-CoA
- Definition
- An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid. It is a member of n-3 PUFA and a product of α-linolenoic acid metabolism.
- References
-
- hmdb:HMDB0060198
- kegg.compound:C16169
- lipidmaps:LMFA07050121
- pubmed:10574660
- pubmed:12897190
- pubmed:1971706
- pubmed:20026368
- pubmed:21184843
- pubmed:7836869
- pubmed:9548590
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
Phenotype where environments contain (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
Phenotype modified by environments containing (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
Phenotype affecting (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA
Human Disease Model